Freedom+ vs Emsella
2025 Pelvic Therapy Equipment Comparison
Choosing the Right Electromagnetic Pelvic Therapy Technology in 2025
As electromagnetic therapies for pelvic floor dysfunction mature, clinics today must evaluate systems not only by efficacy in urinary incontinence, but also by their ability to support broader indications like postpartum rehabilitation, pelvic pain, musculoskeletal dysfunction, and pediatric care.
The rise of functional medicine and multimodal rehabilitation models makes it increasingly important for equipment investments to align with a 5–10 year growth strategy. Platforms that offer clinical flexibility, upgrade pathways, and scalable treatment options are better positioned to adapt to evolving patient demographics and health system demands.
While first-generation HIFEM platforms like Emsella helped establish electromagnetic neuromodulation in urogynecology, next-generation FMS technologies—such as Freedom+—expand treatment versatility, patient populations, and business scalability without sacrificing core clinical outcomes.
The following comparison aims to provide clinicians, physical therapists, and practice owners with a transparent, clinically-relevant side-by-side review.
Freedom+ Platform (Next-Gen FMS Technology) vs Emsella (1st-Gen HIFEM Platform)
Clinical & Treatment Capability Comparison
| Medical Vertical | Freedom+ | Emsella |
|---|---|---|
| Stress Urinary Incontinence (SUI) | ✓ | ✓ |
| Urge Incontinence (OAB) | ✓ | ✓ |
| Mixed Incontinence | ✓ | ✓ |
| Women's Pelvic Health | ✓ | ✓ |
| Postpartum Rehabilitation | ✓ | ✓ |
| Menopausal Pelvic Dysfunction | ✓ | ✓ |
| Vaginal Health / Feminine Wellness | ✓ | ✗ |
| Pelvic Organ Prolapse (POP) | ✓ | ✗ |
| Chronic Pelvic Pain | ✓ | ✗ |
| General Pain Management | ✓ | ✗ |
| Core Muscle Strengthening | ✓ | Limited |
| Musculoskeletal Rehabilitation | ✓ | ✗ |
| Pediatric Urology | ✓ | ✗ |
| Men’s Health (Post-Prostate) | ✓ | ✗ |
| Gerontology Pelvic Care | ✓ | ✗ |
| Gastrointestinal Support | ✓ | ✗ |
Technology & Business Model Comparison
| Factor | Freedom+ | Emsella |
|---|---|---|
| Magnetic Output | 3.0 Tesla / 28,000 Contractions | 2.5 Tesla / 11,000 Contractions |
| Stimulation Type | Dynamic Adaptive FMS | Static HIFEM |
| Clinical Indications | Incontinence, Pain, Pediatrics, Musculoskeletal | Incontinence |
| Upgrade Paths | Yes (Pain, Vaginal, Pediatric) | No |
| Licensing Fees | None | Yes (Annual) |
| Starting Cost | $95k–$125k | $130k–$179k |
| Break-Even ROI | 3–5 Months | 6–12 Months |
| FDA Clearances | Incontinence, Pain, Pediatric | Incontinence |
Which Technology Is Right for Your Clinic?
If your practice focuses solely on urinary incontinence, Emsella remains a valid option. However, for clinics treating broader pelvic, musculoskeletal, pain, and pediatric indications, Freedom+ offers the clinical scalability and business flexibility needed for 2025 and beyond.